Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ana Matas-García
Observed names:
A. Matas-García,
Ana Matas,
Ana Matas Garcia,
Ana Matas García,
Ana Matas-Garcia,
Ana Matas‐Garcia,
Matas-García A
show all 7
Institutions:
Centre for Biomedical Network Research on Rare Diseases,
Hospital Clínic de Barcelona,
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer,
Universitat de Barcelona
Observed institutions:
Instituto de Salud Carlos III,
Centre for Biomedical Network Research on Rare Diseases,
Hospital Clínic de Barcelona,
Fundació Clínic per a la Recerca Biomèdica,
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer,
Universitat de Barcelona
show all 6
ORCID:
0000-0002-9184-8079
Observed ORCID:
0000-0002-9184-8079
OpenAlex ID:
A5086813248
Pathological autoantibody internalisation in myositis
2024
·
Iago Pinal-Fernandez
, Iago Pinal-Fernandez
, et al.
·
Annals of the Rheumatic Diseases
·
100
PDF
Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern
2019
·
Ana Matas-García
, José C. Milisenda
, et al.
·
Autoimmunity Reviews
·
69
Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
2023
·
Elianet Fonseca
, Jose M Cabrera-Maqueda
, et al.
·
The Lancet Neurology
·
63
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis
2023
·
Iago Pinal-Fernandez
, Angela Quintana
, et al.
·
Annals of the Rheumatic Diseases
·
63
PDF
Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy
2018
·
Lida M Rodas
, Ana Matas-García
, et al.
·
Clinical Kidney Journal
·
43
PDF
Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies
2023
·
Iago Pinal-Fernandez
, Jose Cesar Milisenda
, et al.
·
Annals of the Rheumatic Diseases
·
40
PDF
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature
2023
·
Néstor López Guerra
, Ana Matas-García
, et al.
·
Autoimmunity Reviews
·
33
PDF
Gastrointestinal Involvement in Dermatomyositis
2022
·
Ana Matas-Garcia
, José C. Milisenda
, et al.
·
Diagnostics
·
25
PDF
Clinico–pathological phenotypes of systemic sclerosis–associated myopathy: analysis of a large multicentre cohort
2022
·
Ana Matas-García
, Alfredo Guillén-Del-Castillo
, et al.
·
Lara D. Veeken
·
20
Treatment and Monitoring of Eosinophilic Fasciitis
2025
·
Albert Selva-O’Callaghan
, Ernesto Trallero-Araguás
, et al.
·
Current Treatment Options in Rheumatology
·
10
PDF
Coordinated local RNA overexpression of complement induced by interferon gamma in myositis
2023
·
Maria Casal-Dominguez
, Iago Pinal-Fernandez
, et al.
·
Scientific Reports
·
9
PDF
Systemic Sclerosis-Associated Myopathy: How to Treat
2023
·
A. Selva-O’Callaghan
, A. Guillen-Del-Castillo
, et al.
·
Current Treatment Options in Rheumatology
·
8
PDF
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease
2024
·
Agustin Hidalgo‐Gutierrez
, Jonathan Shintaku
, et al.
·
Annals of Neurology
·
7
PDF
Anoctamin 5 (ANO5) muscular dystrophy—three different phenotypes and a new histological pattern
2020
·
Ferran Seguí
, Lidia Gonzalez-Quereda
, et al.
·
Neurological Sciences
·
7
Pathogenic autoantibody internalization in myositis
2024
·
Iago Pinal-Fernandez
, Sandra Muñoz-Braceras
, et al.
·
medRxiv
·
6
PDF
Treatment of Myositis Associated With Immune Checkpoint Inhibitors
2023
·
Ana Matas-García
, Eugenia Martinez-Hernandez
, et al.
·
Current Treatment Options in Rheumatology
·
5
Treatment Algorithms for Inflammatory Myopathies in Adults: from Guidelines to Clinical Practice
2025
·
Albert Selva-O’Callaghan
, Ernesto Trallero-Araguás
, et al.
·
Current Treatment Options in Rheumatology
·
3
PDF
Untargeted Metabolomic Study for Urinary Characterization of Adult Patients with Phenylketonuria
2025
·
Arnau Gonzalez-Rodriguez
, Blanca Barrau-Martinez
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Clinical Outcomes of Patients with Chronic Neuropathic Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective Study
2023
·
Sinziana Stanescu
, Patricia Correcher Medina
, et al.
·
Biomedicines
·
3
PDF
FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities
2022
·
José Hernández-Rodríguez
, Julio Durán-Sanclemente
, et al.
·
Clinical Drug Investigation
·
3
PDF
Encefalopatía inducida por disulfiram intranasal: resultados clínicos y de neuroimagen
2022
·
Ana Matas García
, Adrián Téllez
, et al.
·
Revista de Neurología
·
3
PDF
Sporadic inclusion body myositis: Diagnostic value of p62 immunostaining
2019
·
José C. Milisenda
, Ana Matas García
, et al.
·
Medicina Clínica
·
2
Case Report: Thymoma-associated myasthenia gravis, myositis, myocarditis, and anti-GAD65 autoimmune encephalitis: a unique case of paraneoplastic polyautoimmunity
2026
·
Enmanuel A. Leiva-Murillo
, Eugenia Martínez-Hernández
, et al.
·
Frontiers in Immunology
·
1
PDF
Finding the cause of severe hypokalemia: A 4-step approach
2025
·
Enmanuel A. Leiva-Murillo
, Erwin Bechtold-Javier
, et al.
·
Cleveland Clinic Journal of Medicine
·
1
PDF
Enfermedad de Pompe
2025
·
José César Milisenda
, Ana Matas-García
·
Medicina Clínica
·
1
Show more works
View as search
Works count:
44
Citation count:
530
H-index:
10
I10-index:
10
Year
Topic
Type